Andrew Carter: Dynein Trailblazer

By Hannah Waters Andrew Carter: Dynein Trailblazer Nick Morrish Group Leader, Laboratory of Molecular Biology, Medical Research Council. Age: 36The typical biologist’s desk is strewn with reprints and lab notebooks, maybe a coffee cup, perhaps a small model of a DNA molecule. Structural biologist Andrew Carter’s workspace has all these things, but a cluster of framed dog photographs stands out amid the clutter: his collection of corgi pictu

Written byHannah Waters
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Group Leader, Laboratory of Molecular Biology, Medical Research Council. Age: 36

The typical biologist’s desk is strewn with reprints and lab notebooks, maybe a coffee cup, perhaps a small model of a DNA molecule. Structural biologist Andrew Carter’s workspace has all these things, but a cluster of framed dog photographs stands out amid the clutter: his collection of corgi pictures. “Good science, good beer, and corgis are three of Andrew’s passions,” says his postdoctoral advisor, University of California, San Francisco (UCSF), biologist Ron Vale. He teasingly parodies his advisee: “’When times get tough, all I have to do is to look at these pictures of corgis for release and genuflection.’”

Carter’s “good science,” structural biology, is a discipline that didn’t necessarily come easily to the young researcher. “When you’re taught structural biology as an undergrad, it seems impossible,” Carter says. “It was so mathematical I thought I would never be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies